Targovax ASA announces new member of the Board
Oslo, Norway, 17 March 2021 - Targovax ASA (OSE: TRVX) announces that the General meeting has elected seasoned industry expert Sonia Quaratino MD PhD as new member of the Board of Directors.Dr Quaratino is an R&D executive with over 20 years' experience in clinical development and immunology research. She is Chief Medical Officer at Kymab, a clinical-stage biopharmaceutical company recently acquired by Sanofi with a deal value of approx. USD 1.5bn. She is also the Chair of the Scientific and Clinical Advisory Board for STipe Therapeutics. Prior to her role at Kymab, Dr Quaratino held a